Dear Valued Client, 

We are writing to inform you that Eurofins Diatherix plans to cease providing laboratory testing effective September 30, 2026.

Please note dates below: 

Final day to order supplies, September 15, 2026 

Final day to use electronic ordering such as Webclient and EMR, September 28, 2026

If you have questions regarding this notice or your account, please contact Client Services at clientservices@diatherix.eurofinsus.com or 866.979.4242.

We appreciate the opportunity to have served you and thank you for your business.

Sincerely,

Brian Grajzar 

President Eurofins Diatherix 

Eurofins Diatherix Laboratories LLC 

Eurofins Diatherix is a state-of-the-art CLIA and CAP-accredited laboratory designed to maximize process efficiency and workflow.

Based in Huntsville, Alabama, and located in the Hudson Alpha Institute for Biotechnology, Eurofins Diatherix is a highly specialized laboratory providing cutting-edge molecular diagnostic testing services to hospitals and physicians using proprietary TEM-PCR™ (Target Enriched Multiplex Polymerase Chain Reaction) technology for precise detection of infectious diseases at high levels of sensitivity and specificity, and at very short turnaround times. In addition to proprietary TEM-PCR™, Eurofins Diatherix offers Elisa Testing for fecal biomarker analysist and Urine Culture and Sensitivity testing. 

Eurofins Diatherix has been on the forefront of diagnostic testing since 2008. First as an independent company and then later joining forces with Eurofins to form what is now known as Eurofins Diatherix. Diatherix alone has served over 68,000 clients which has resulted in millions of tests Nationwide. 

Eurofins Diatherix utilizes proprietary TEM-PCR™ and other molecular technologies to deliver fast, accurate and,  actionable results when they are needed the most. Unlike traditional multiplex PCR, which can suffer from competing primer pairs and non-specific amplification, TEM-PCR™ enriches the target DNA before amplification. This crucial step reduces background noise and enhances both the specificity and sensitivity, resulting in reliable and clinically actionable results.  Proprietary TEM-PCR™ improves the success of an accurate clinical diagnosis with the following benefits:

• • Optimizes target amplification conditions that improve both sensitivity and specificity of difficult-to-identify pathogens reducing false negatives, which can lead to missed diagnosis and untreated infections. 

  • Prevents inappropriate treatment such as unnecessary antibiotics or failure to prescribe when needed.

  • Improves the identification of infectious organisms in patients who are already on empirical antibiotic regimens

  • Identifies both viruses and bacteria that have synergistic roles in more complex infections

Accurate detection and co-detection of problematic bacteria and viruses can result in significant improvements during the patient treatment process. Having this precise knowledge can allow the clinician to determine the right course of action and preclude inappropriate antibiotic therapy.

• • Delivers one-day results

  • Identifies bacteria regardless of recent antibiotic use

  • Offers simplicity of single-sample collection

  • Identifies difficult-to-culture pathogens

  • Yields a high level of sensitivity and specificity

Eurofins Diatherix offers a robust, year- round testing solution supporting a wide range of clinical needs, including:  Respiratory Infection, Genital Health, Gastrointestinal, Wound, Skin & Soft Tissue and Urinary Tract 

With a comprehensive test menu and  a commitment to precision, Eurofins Diatherix empowers healthcare providers with the insights they need to deliver timely, informed care. 

Partner with Eurofins Diatherix to enhance your diagnostic capabilities and provide the best care to your patients.